Chemoinformaics analysis of 4,5-DIHYDROXY-3,8-DIMETHYLNAPHTHALENE-1,2-DIONE
Molecular Weight | 218.208 | nRot | 0 |
Heavy Atom Molecular Weight | 208.128 | nRig | 4 |
Exact Molecular Weight | 218.058 | nRing | 2 |
Solubility: LogS | -2.003 | nHRing | 0 |
Solubility: LogP | 2.179 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
nHA | 4 | APOL | 29.9159 |
nHD | 2 | BPOL | 11.7681 |
QED | 0.378 |
Synth | 2.405 |
Natural Product Likeliness | 0.265 |
NR-PPAR-gamma | 0.014 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0 |
HIA | 0.002 |
CACO-2 | -4.46 |
MDCK | 0.0000907 |
BBB | 0.649 |
PPB | 0.476126 |
VDSS | 1.007 |
FU | 0.567341 |
CYP1A2-inh | 0.97 |
CYP1A2-sub | 0.722 |
CYP2c19-inh | 0.853 |
CYP2c19-sub | 0.481 |
CYP2c9-inh | 0.678 |
CYP2c9-sub | 0.077 |
CYP2d6-inh | 0.032 |
CYP2d6-sub | 0.107 |
CYP3a4-inh | 0.037 |
CYP3a4-sub | 0.232 |
CL | 12.388 |
T12 | 0.796 |
hERG | 0.089 |
Ames | 0.043 |
ROA | 0.017 |
SkinSen | 0.948 |
Carcinogencity | 0.039 |
EI | 0.992 |
Respiratory | 0.063 |
NR-Aromatase | 0.727 |
Antiviral | No |
Prediction | 0.670933 |